Back to Treatments

Treatment

Linezolid (as part of an optimized background regimen for MDR-TB)

1
Conditions
50
Trials
10K
Participants
50%
Average Safety

Condition Evidence

HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance

50 trials · 10K participants

75% effectiveness · 50% safety
Linezolid (as part of an optimized background regimen for MDR-TB) | DFDA